Free Trial
OTCMKTS:EVARF

Lombard Medical (EVARF) Stock Price, News & Analysis

Lombard Medical logo

About Lombard Medical Stock (OTCMKTS:EVARF)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Lombard Medical was a medical device company focused on products for the minimally invasive treatment of abdominal aortic aneurysms (AAAs). Its principal product was the Aorfix endovascular stent graft, designed to reinforce weakened sections of the aorta and provide an alternative to open surgical repair.

The company also developed delivery systems and related technologies intended to help physicians position and deploy endovascular grafts during aneurysm repair procedures. Aorfix was marketed internationally and received regulatory clearances, including approval for use in the United States.

Lombard Medical was headquartered in the United Kingdom and served hospitals and vascular specialists in multiple international markets. The company was acquired by MicroPort Scientific Corporation in 2016, after which Lombard Medical became part of MicroPort’s medical-device operations.

AI Generated. May Contain Errors.

Receive EVARF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lombard Medical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EVARF Stock News Headlines

I'm giving you a space stock today. Free.
On December 8th, $600 billion in frozen SpaceX stock comes loose. Dylan Jovine says one simple purchase in any regular brokerage account gives investors exposure to SpaceX and 66 of its neighbors, without an IPO allocation. He is also naming two space stocks he would consider dumping before December, plus a $14 stock that Elon has personally put his name on.tc pixel
See More Headlines

EVARF Stock Analysis - Frequently Asked Questions

Lombard Medical, Inc. (OTCMKTS:EVARF) posted its quarterly earnings results on Thursday, October, 27th. The medical equipment provider reported ($0.37) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by $0.11. The medical equipment provider had revenue of $3.04 million for the quarter, compared to analysts' expectations of $3.16 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that Lombard Medical investors own include Celldex Therapeutics (CLDX), Plus Therapeutics (PSTV), PayPal (PYPL), Can-Fite BioPharma (CANF), Ayala Pharmaceuticals (ADXS), Advanced Micro Devices (AMD) and Athersys (ATHX).

Company Calendar

Last Earnings
10/27/2016
Today
10/14/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
OTCMKTS:EVARF
Previous Symbol
NASDAQ:EVAR
CIK
N/A
Employees
111
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (OTCMKTS:EVARF) was last updated on 10/7/2026 by MarketBeat.com Staff.
From Our Partners